Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet–fed mice
| Autor: | Roberto Soares de Moura, Lenize Costa Reis Marins de Carvalho, Angela Castro Resende, Ana Paula Machado da Rocha, Cristiane Aguiar da Costa, Izabelle Barcellos Santos, Graziele Freitas de Bem, Viviane da Silva Cristino Cordeiro, Dayane Teixeira Ognibene, Gisele França da Costa |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
0301 basic medicine medicine.medical_specialty Endocrinology Diabetes and Metabolism Diet High-Fat Antioxidants Mice Phosphatidylinositol 3-Kinases 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Endocrinology Insulin resistance Internal medicine Nonalcoholic fatty liver disease medicine Hyperinsulinemia Animals Insulin Vitis Obesity Triglycerides Glucose Transporter Type 2 Nutrition and Dietetics biology Triglyceride Plant Extracts Lipogenesis Polyphenols medicine.disease Cyclin-Dependent Kinases Fatty Liver Mice Inbred C57BL Oxidative Stress Insulin receptor Cholesterol 030104 developmental biology Liver chemistry 030220 oncology & carcinogenesis Insulin Receptor Substrate Proteins biology.protein GLUT2 Insulin Resistance Steatosis Cyclin-Dependent Kinase-Activating Kinase |
| Zdroj: | Nutrition Research. 43:69-81 |
| ISSN: | 0271-5317 |
| DOI: | 10.1016/j.nutres.2017.05.007 |
| Popis: | Nonalcoholic fatty liver disease is one of the most common complications of obesity. The Vitis vinifera L. grape skin extract (ACH09) is an important source of polyphenols, which are related to its antioxidant and antihyperglycemic activities. We hypothesized that ACH09 could also exert beneficial effects on metabolic disorders associated with obesity and evaluated ACH09's influence on high-fat (HF) diet-induced hepatic steatosis and insulin resistance in C57BL/6 mice. The animals were fed a standard diet (10% fat, control) or an HF diet (60% fat, HF) with or without ACH09 (200mg/[kg d]) for 12weeks. Our results showed that ACH09 reduced HF diet-induced body weight gain, prevented hepatic lipid accumulation and steatosis, and improved hyperglycemia and insulin resistance. The underlying mechanisms of these beneficial effects of ACH09 may involve the activation of hepatic insulin-signaling pathway because the expression of phosphorylated insulin receptor substrate-1, phosphatidylinositol 3-kinase, phosphorylated Akt serine/threonine kinase 1, and glucose transporter 2 was increased by ACH09 and correlated with improvement of hyperglycemia, hyperinsulinemia, and insulin resistance. ACH09 reduced the expression of the lipogenic factor sterol regulatory-element binding protein-1c in the liver and upregulated the lipolytic pathway (phosphorylated liver kinase B1/phosphorylated adenosine-monophosphate-activated protein kinase), which was associated with normal hepatic levels of triglyceride and cholesterol and prevention of steatosis. ACH09 prevented the hepatic oxidative damage in HF diet-fed mice probably by restoration of antioxidant activity. In conclusion, ACH09 protected mice from HF diet-induced obesity, insulin resistance, and hepatic steatosis. The regulation of hepatic insulin signaling pathway, lipogenesis, and oxidative stress may contribute to ACH09's protective effect. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect